Introduction: Why a Structured Protocol Matters
Vascular dementia (VaD) is the second most common cause of dementia globally after Alzheimer's disease, and is responsible for approximately 20% of all dementia cases. It results from cerebrovascular disease — multiple small infarcts, strategic single infarcts, or diffuse small vessel disease causing white matter damage.
Unlike Alzheimer's disease (which progresses gradually), vascular dementia characteristically follows a stepwise deterioration — stable periods interrupted by abrupt functional declines after new vascular events. This means that preventing new vascular events is as important as treating existing cognitive symptoms.
Eber Medical Group uses a three-stage structured protocol for vascular dementia — combining the gold-standard Western neurological diagnostic workup with Traditional Chinese Medicine (TCM) assessment, followed by multidisciplinary pharmacotherapy + TCM treatment, and concluding with ongoing monitoring and caregiver education.
STAGE 1: Comprehensive Diagnosis and Confirmation
1.1 In-Depth Clinical Neurological Assessment
The foundation of diagnosis. The neurologist conducts a detailed consultation with both the patient and a reliable family member or caregiver — essential, as patients often lack insight into their own cognitive decline:
- Detailed symptom onset and progression: was it sudden (post-stroke) or gradual?
- Vascular risk factor history: hypertension, diabetes, atrial fibrillation, smoking, hyperlipidemia
- Previous TIA or stroke history
- Functional decline timeline: driving, finances, medication management, ADL
- Behavioral changes: apathy, irritability, depression, disinhibition, sleep disturbance
Neurological examination assesses: cranial nerves, motor system (particular attention to pyramidal signs — hyperreflexia, extensor plantar responses — characteristic of vascular dementia), coordination, gait, and posture.
1.2 Neuropsychological Testing — The Cognitive Blueprint
This is one of the most critical components of vascular dementia diagnosis:
- MMSE (Mini-Mental State Examination): Global cognitive screening; useful baseline and follow-up measure
- MoCA (Montreal Cognitive Assessment): Specifically designed to detect the executive dysfunction and attention deficits characteristic of vascular dementia (as opposed to the memory-predominant profile of early Alzheimer's)
- Extended neuropsychological battery: Memory (verbal and visual, immediate and delayed), executive functions (frontal lobe testing — clock drawing, trail-making, verbal fluency), attention and processing speed, language, and visuospatial functions
- Behavioral and mood assessment: Neuropsychiatric Inventory (NPI) for apathy, irritability, depression; sleep quality scale
1.3 Laboratory Diagnostics
- CBC with differential, ESR — infection, inflammation
- Comprehensive metabolic panel — glucose, HbA1c, lipids, thyroid, renal, hepatic
- Coagulation panel — for patients with thrombotic vascular events
- Infection screen — syphilis, Lyme, HIV (if indicated)
- Inflammatory markers — CRP, homocysteine (vascular risk)
1.4 Neuroimaging — Gold Standard
MRI at Eber (Philips 3.0T) using a dedicated vascular dementia protocol:
- T1-weighted: Cortical and subcortical atrophy, lacunar infarcts
- T2/FLAIR: White matter hyperintensities (Fazekas grading), periventricular leukoaraiosis, cortical/subcortical infarcts
- DWI: Acute ischemic lesions (if recent event suspected)
- SWI: Cerebral microbleeds — critical for anticoagulation risk assessment
- CT if MRI contraindicated
1.5 Vascular Assessment
- USDG (Doppler ultrasound): Carotid intima-media thickness, stenosis assessment bilaterally
- MRA (MR Angiography) or CTA: Intracranial and cervical vessel assessment
- Holter ECG: Atrial fibrillation detection — major embolic stroke risk factor
- Echocardiography: Cardiac source of embolism
1.6 Additional Methods (Indicated Cases)
- EEG — rule out epileptiform activity (seizures can exacerbate cognitive decline)
- PET/SPECT — metabolic pattern; distinguishes vascular dementia from Alzheimer's
1.7 TCM Comprehensive Diagnostic Assessment
Running in parallel with the Western workup, the senior TCM physician conducts a full canonical assessment:
- Detailed TCM interview: Onset in TCM terms, appetite, digestion, sleep, emotional state, cold/heat tolerance
- Tongue diagnosis: Coating (thick/thin, yellow/white/grey/black), body color (pale — deficiency; purple — stasis; red — heat), texture (cracks, teeth marks)
- Pulse diagnosis: 28 classical pulse qualities — identifying organ imbalances. In vascular dementia: typically thin and wiry (liver-kidney deficiency) with choppy quality (blood stasis) or slippery (phlegm)
- Syndrome differentiation: Most commonly assigns one or more of: kidney essence deficiency, blood stasis, phlegm-damp obstruction, or qi deficiency — each requiring a different herbal and acupuncture approach
- TCM treatment plan developed: Individualized herbal formula + acupuncture protocol
STAGE 2: Multidisciplinary Treatment
The treatment goal for vascular dementia is fourfold: (1) prevent new vascular events, (2) slow cognitive decline, (3) manage behavioral and psychological symptoms, and (4) support functional independence. Our integrated Western medicine + TCM multidisciplinary approach addresses all four simultaneously.
2.1 Vascular Risk Factor Management
This is the most evidence-based intervention for halting vascular dementia progression:
- Blood pressure control: Target <130/80 mmHg (individualized). Overly aggressive treatment in elderly patients can worsen cerebral perfusion — careful titration
- Antiplatelet therapy: Aspirin 75–100mg or clopidogrel — reduces microembolic events
- Anticoagulation: For atrial fibrillation — direct oral anticoagulants (DOACs) preferred
- Lipid management: Statin therapy targeting LDL <1.8 mmol/L — reduces atherosclerotic plaque progression
- Glucose control: HbA1c target 7–8% (avoiding hypoglycemia in elderly)
2.2 Cognitive Pharmacotherapy
- Acetylcholinesterase inhibitors: Donepezil or rivastigmine — particularly effective in the mixed dementia (VaD + Alzheimer's overlap) phenotype
- NMDA receptor antagonist: Memantine — for moderate-severe dementia; slows progression
- Neuroprotectives: Brain metabolic support agents — improve cerebral blood flow and neuronal metabolism
- Management of behavioral symptoms: SSRIs for depression/apathy; low-dose antipsychotics only when necessary for severe agitation (with careful monitoring)
2.3 Non-Pharmacological Rehabilitation
- Cognitive training: Structured programs targeting memory, attention, and executive function — using computer-based and therapist-led approaches
- Physiotherapy: Balance, gait stability, falls prevention — particularly important in vascular dementia where motor signs are common
- Occupational therapy: Home safety assessment, ADL training, environmental modification, caregiver techniques
- Speech therapy: For patients with dysarthria or swallowing difficulties from cerebrovascular involvement
- Psychosocial: Art therapy, music therapy, reminiscence therapy — maintain emotional engagement and slow behavioral deterioration
- Dietary therapy: Mediterranean diet pattern shown to reduce dementia risk and progression; personalized nutrition counseling
2.4 TCM Treatment
- Individualized herbal medicine: For kidney essence deficiency + blood stasis — Bushen Huoxue formula (Rehmannia, Cornus, Salvia, Carthamus). For phlegm-damp obstruction — Di Tan Tang variant. Prescriptions reviewed monthly.
- Scalp acupuncture: Memory and cognition zones (Baihui GV20, Sishencong, temporal lines MS6/MS7) — increases cerebral blood flow, activates resting-state networks
- Body acupuncture: Zusanli ST36, Neiguan PC6, Sanyinjiao SP6, Taixi KI3 — tonification and blood stasis resolution points
- Moxa therapy: At Guanyuan CV4, Zhongwan CV12, Zusanli ST36 — tonifies spleen-kidney Yang; improves Qi and blood production
- Tuina: Head and neck massage — improves lymphatic drainage from brain; reduces rigidity; improves circulation
- TCM dietary therapy: Kidney-nourishing foods (walnuts, black sesame, goji, black beans); avoid damp-generating foods (cold dairy, raw foods, sugar excess)
STAGE 3: Monitoring, Follow-Up, and Caregiver Support
- Regular neurologist follow-up: During the treatment program and ongoing monitoring
- Cognitive reassessment: MoCA/MMSE at 3 and 6 months to document trajectory
- Vascular risk monitoring: Blood pressure diaries, HbA1c every 3 months, lipid panel every 6 months
- Caregiver education program: How to communicate with a person with dementia; behavioral management techniques; caregiver stress management; legal and financial planning guidance
- Telemedicine follow-up (international patients): Video consultations at 1, 3, and 6 months post-discharge